98 related articles for article (PubMed ID: 11587364)
1. Oncogenic mechanisms of Evi-1 protein.
Hirai H; Izutsu K; Kurokawa M; Mitani K
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S35-40. PubMed ID: 11587364
[TBL] [Abstract][Full Text] [Related]
2. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling.
Izutsu K; Kurokawa M; Imai Y; Maki K; Mitani K; Hirai H
Blood; 2001 May; 97(9):2815-22. PubMed ID: 11313276
[TBL] [Abstract][Full Text] [Related]
3. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1.
Alliston T; Ko TC; Cao Y; Liang YY; Feng XH; Chang C; Derynck R
J Biol Chem; 2005 Jun; 280(25):24227-37. PubMed ID: 15849193
[TBL] [Abstract][Full Text] [Related]
4. The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3.
Kurokawa M; Mitani K; Irie K; Matsuyama T; Takahashi T; Chiba S; Yazaki Y; Matsumoto K; Hirai H
Nature; 1998 Jul; 394(6688):92-6. PubMed ID: 9665135
[TBL] [Abstract][Full Text] [Related]
5. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
Kurokawa M; Mitani K; Imai Y; Ogawa S; Yazaki Y; Hirai H
Blood; 1998 Dec; 92(11):4003-12. PubMed ID: 9834202
[TBL] [Abstract][Full Text] [Related]
6. Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP.
Nitta E; Izutsu K; Yamaguchi Y; Imai Y; Ogawa S; Chiba S; Kurokawa M; Hirai H
Oncogene; 2005 Sep; 24(40):6165-73. PubMed ID: 15897867
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
Mitani K
Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
[TBL] [Abstract][Full Text] [Related]
8. Evi-1 promotes para-aortic splanchnopleural hematopoiesis through up-regulation of GATA-2 and repression of TGF-b signaling.
Sato T; Goyama S; Nitta E; Takeshita M; Yoshimi M; Nakagawa M; Kawazu M; Ichikawa M; Kurokawa M
Cancer Sci; 2008 Jul; 99(7):1407-13. PubMed ID: 18452556
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer.
Deng X; Cao Y; Liu Y; Li F; Sambandam K; Rajaraman S; Perkins AS; Fields AP; Hellmich MR; Townsend CM; Thompson EA; Ko TC
Mol Carcinog; 2013 Apr; 52(4):255-264. PubMed ID: 22161860
[TBL] [Abstract][Full Text] [Related]
10. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins.
Palmer S; Brouillet JP; Kilbey A; Fulton R; Walker M; Crossley M; Bartholomew C
J Biol Chem; 2001 Jul; 276(28):25834-40. PubMed ID: 11328817
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor Evi-1.
Hirai H
Int J Biochem Cell Biol; 1999 Dec; 31(12):1367-71. PubMed ID: 10641791
[TBL] [Abstract][Full Text] [Related]
12. The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.
Izutsu K; Kurokawa M; Imai Y; Ichikawa M; Asai T; Maki K; Mitani K; Hirai H
Oncogene; 2002 Apr; 21(17):2695-703. PubMed ID: 11965542
[TBL] [Abstract][Full Text] [Related]
13. Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain.
Tanaka T; Nishida J; Mitani K; Ogawa S; Yazaki Y; Hirai H
J Biol Chem; 1994 Sep; 269(39):24020-6. PubMed ID: 7929053
[TBL] [Abstract][Full Text] [Related]
14. The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding protein.
Tomita M; Choe J; Tsukazaki T; Mori N
Oncogene; 2004 Oct; 23(50):8272-81. PubMed ID: 15467747
[TBL] [Abstract][Full Text] [Related]
15. [Leukemogenesis by the AML1/EVI-1 chimeric protein].
Mitani K; Hirai H
Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):33-9. PubMed ID: 10643333
[No Abstract] [Full Text] [Related]
16. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.
Bartholomew C; Ihle JN
Mol Cell Biol; 1991 Apr; 11(4):1820-8. PubMed ID: 1848663
[TBL] [Abstract][Full Text] [Related]
17. SMAD3 represses androgen receptor-mediated transcription.
Hayes SA; Zarnegar M; Sharma M; Yang F; Peehl DM; ten Dijke P; Sun Z
Cancer Res; 2001 Mar; 61(5):2112-8. PubMed ID: 11280774
[TBL] [Abstract][Full Text] [Related]
18. The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death.
Kurokawa M; Mitani K; Yamagata T; Takahashi T; Izutsu K; Ogawa S; Moriguchi T; Nishida E; Yazaki Y; Hirai H
EMBO J; 2000 Jun; 19(12):2958-68. PubMed ID: 10856240
[TBL] [Abstract][Full Text] [Related]
19. The EVI-1 gene--its role in pathogenesis of human leukemias.
Jółkowska J; Witt M
Leuk Res; 2000 Jul; 24(7):553-8. PubMed ID: 10867128
[TBL] [Abstract][Full Text] [Related]
20. The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase.
Vinatzer U; Taplick J; Seiser C; Fonatsch C; Wieser R
Br J Haematol; 2001 Sep; 114(3):566-73. PubMed ID: 11552981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
